Fullerene C.sub.60 Attenuates Heart Tissue Inflammation by Modulating COX-2 and TNF-Alpha Signaling Pathways in DMBA Induced Breast Cancer in Rats

• Published in: Cardiovascular toxicology 2023-02, Vol.23 (2), p.75
• Main Authors: Beyaz, Seda, Aslan, Abdullah, Gok, Ozlem, Agca, Can Ali, Ozercan, Ibrahim Hanifi
• Format: Article
• Language: English
• Subjects: Breast cancer; Ethylenediaminetetraacetic acid; Health aspects; Inflammation; Tumor necrosis factor; Tumor proteins
• ISSN: 1530-7905
• DOI: 10.1007/s12012-023-09780-y

The present study aimed to investigate the therapeutic effect of fullerene C.sub.60 nanoparticle against heart tissue damage caused by 7,12-dimethylbenz [a] anthracene (DMBA) in female rats. Female Wistar albino rats, 8 weeks old (n = 60) weighing around (150 ± 10 g) were used for the study. These rats were divided into 4 groups and each group included 15 rats. Groups: (i) Control Group: Fed with standard diet; (ii) C.sub.60 Group: C.sub.60 (1.7 mg/kg bw, oral gavage); (iii) DMBA Group: DMBA (45 mg/kg bw, oral gavage); (iv) C.sub.60 and DMBA Group: C.sub.60 (1.7 mg/kg bw, oral gavage) and DMBA (45 mg/kg bw, oral gavage) group. Malondialdehyde (MDA) analysis, catalase activity (CAT), and glutathione (GSH) in heart tissue were determined by spectrophotometer. In addition, heart tissue DNA damage was investigated. Caspase-3, p53, HO-1, COX-2, and TNF-[alpha] protein expression levels in heart tissue were determined by western blotting. As a result, Caspase-3, p53, HO-1 protein expression, GSH levels and CAT activity increased, COX-2, TNF-[alpha] protein expression, and MDA levels were significantly decreased in the C.sub.60 + DMBA group compared to the DMBA group. Therefore, the fullerene C.sub.60 nanoparticle may be a promising and effective therapy for the treatment of heart diseases associated with inflammation.